These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11694404)

  • 1. Evaluation of an automated method for the quantification of von Willebrand factor antigen. Its application in the study of vascular dysfunction.
    Villa P; Iborra J; Serra J; Gilsanz A; Casaña P; Aznar JA; Aznar J
    Haematologica; 2001 Nov; 86(11):1180-5. PubMed ID: 11694404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an automated platelet-based assay of ristocetin cofactor activity.
    Lawrie AS; Mackie IJ; Machin SJ; Peyvandi F
    Haemophilia; 2011 Mar; 17(2):252-6. PubMed ID: 21070498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the von Willebrand factor antigen (vWF-Ag) assay using an immuno-turbidimetric method (STA Liatest vWF) automated on the MDA 180 coagulometer.
    Sukhu K; Martin PG; Cross L; Keeling DM; Giangrande PL
    Clin Lab Haematol; 2000 Feb; 22(1):29-32. PubMed ID: 10762301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand factor in diabetic retinopathy.
    Abayomi EA; Miller E; Paton RC
    Cent Afr J Med; 1996 Jul; 42(7):205-6. PubMed ID: 8936786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new automated screening assay for the diagnosis of von Willebrand disease.
    Salem RO; Van Cott EM
    Am J Clin Pathol; 2007 May; 127(5):730-5. PubMed ID: 17439831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a new automated von Willebrand factor activity assay with an aggregation von Willebrand ristocetin cofactor activity assay for the diagnosis of von Willebrand disease.
    De Vleeschauwer A; Devreese K
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):353-8. PubMed ID: 16788311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Content and functional activity of von Willebrand factor in apheresis plasma.
    Burnouf T; Caron C; Burkhardt T; Goudemand J
    Vox Sang; 2004 Jul; 87(1):27-33. PubMed ID: 15260819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of the factor VIII/von Willebrand factor concentrate, haemate-P/humate-P: ristocetin cofactor unit dosing in patients with von Willebrand disease.
    Lillicrap D; Poon MC; Walker I; Xie F; Schwartz BA;
    Thromb Haemost; 2002 Feb; 87(2):224-30. PubMed ID: 11858481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD.
    Castaman G; Tosetto A; Cappelletti A; Goodeve A; Federici AB; Batlle J; Meyer D; Goudemand J; Eikenboom JC; Schneppenheim R; Budde U; Ingerslev J; Lethagen S; Hill F; Peake IR; Rodeghiero F
    Thromb Res; 2010 Sep; 126(3):227-31. PubMed ID: 20650506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of von Willebrand factor activity: evaluation of the HaemosIL assay in comparison with established procedures.
    Sucker C; Senft B; Scharf RE; Zotz RB
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):305-10. PubMed ID: 16959683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Von Willebrand factor in type 1 diabetes: its production and coronary artery calcification.
    Chan NN; Fuller JH; Rubens M; Colhoun HM
    Med Sci Monit; 2003 Jul; 9(7):CR297-303. PubMed ID: 12883448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered endothelial function following the Fontan procedure.
    Binotto MA; Maeda NY; Lopes AA
    Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of evaluating conventional inflammatory markers in Von Willebrand factor measurement.
    Lippi G; Franchini M; Targher G; Poli G; Guidi GC
    Clin Chim Acta; 2007 Jun; 381(2):167-70. PubMed ID: 17433810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of von Willebrand factor in cardiac allograft vasculopathy: preliminary experience.
    Chamorro CI; Almenar L; Martínez-Dolz L; Reganon E; Sánchez-Lacuesta E; Villa P; Ten F; Andrés L; Martínez-Sales V; Salvador A
    Transplant Proc; 2006 Oct; 38(8):2566-8. PubMed ID: 17098004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
    Giannini S; Mezzasoma AM; Leone M; Gresele P
    Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications.
    De Mattia G; Bravi MC; Laurenti O; Moretti A; Cipriani R; Gatti A; Mandosi E; Morano S
    Diabetes Res Clin Pract; 2008 Feb; 79(2):337-42. PubMed ID: 17949845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
    Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M
    J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of immunoturbidimetric specific protein methods using the Architect ci8200: comparison with immunonephelometry.
    Denham E; Mohn B; Tucker L; Lun A; Cleave P; Boswell DR
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):529-36. PubMed ID: 17961307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
    Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
    Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Von Willebrand factor antigen levels in Behçet disease.
    Beyan E; Sadikoğlu B; Ertuğrul E; Beyan C
    Am J Hematol; 2005 May; 79(1):70-2. PubMed ID: 15849757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.